The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
December 2012, Volume 19 Issue 6
In a special introduction, new EJHP Editor Phil Wiffin outlines his vision for the future of the Journal, including underpinning the publication with an evidence-based philosophy, widening its coverage in relation to clinical pharmacy service delivery and broadening the quantity and quality of submitted articles, including the development of a novice authors section.
In an opinion piece, Professor Per Hartvig Honoré considers whether personalised medicine can ever truly become a reality.
In an article on reporting guidelines, Dr Sally Hopewell and Dr Iveta Simera explore the importance of transparent and clear reporting of research and the problems caused by poor reporting. In so doing, the authors consider the impact of the CONSORT Statement and the activity of the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network.
In the third in a series of articles summarising the results of the EAHP 2010 Survey Dr. Roberto Frontini highlights analysis of the survey questions relating to hospital pharmacy production of medicines, and quality assurance processes.
A research article evaluates whether patient bedside medicine lockers result in a safer and faster medicine administration round. The study was conducted across a number of hospital wards in Northern Ireland and found the introduction of the lockers resulted in safer and faster medicine administration rounds.
Another research article examines the impact of clinical pharmacist interventions in a large Austrian tertiary care hospital. The study explored the various types of drug-related problems detected during clinical pharmacist ward rounds, and the acceptance rate of the clinical pharmacist’s interventions.
Finally, a series of articles provide a Country Focus on hospital pharmacy practise in Denmark, including policies towards Drug Manufacturing, the implementation of clinical pharmacy in Danish hospitals and the use of new standards for parenteral nutrition for children.